| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 50.0K | $932.5K | - | |
| CFO | 47.4K | $884.5K | - | |
| Dir | 22.6K | $421.2K | - | |
| Other | 15.0K | $279.8K | - | |
| Other | 13.6K | $253.2K | -8,148 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,596 | $17.01 | $27,152.91 | -7.4% | +54.9% | -24.7% | |
| May 2, 2024 | Van Houte Hans60 | Chief Financial Officer | Sell | 3,499 | $12.83 | $44,878.17 | -4.9% | +71.9% | -11.5% | |
| Apr 30, 2024 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 2,007 | $12.04 | $24,168.70 | -4.8% | +76.8% | -4.1% | |
| Apr 30, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,513 | $12.04 | $18,219.85 | -7.1% | +76.8% | -4.1% | |
| Apr 30, 2024 | Van Houte Hans60 | Chief Financial Officer | Sale+OE | 1,387 | $12.04 | $16,702.53 | -1.9% | +76.8% | -4.1% | |
| Feb 16, 2024 | Van Houte Hans60 | Chief Financial Officer | Sell | 6,812 | $10.02 | $68,222.86 | -9.1% | +56.0% | +78.2% | |
| Jan 30, 2024 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 2,334 | $7.99 | $18,649.13 | -6.0% | +56.1% | +145.9% | |
| Jan 30, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,760 | $7.99 | $14,062.75 | -9.2% | +56.1% | +145.9% | |
| Jan 30, 2024 | Van Houte Hans60 | Chief Financial Officer | Sale+OE | 1,671 | $7.99 | $13,351.62 | -2.2% | +56.1% | +145.9% | |
| Dec 20, 2023 | Van Houte Hans60 | Chief Financial Officer | Sell | 3,541 | $10.00 | $35,420.98 | -4.7% | +29.6% | +103.9% |